Compounds > 3,4-dihydroxybenzohydroxamic acid
Page last updated: 2024-10-26

3,4-dihydroxybenzohydroxamic acid and Glial Cell Tumors

3,4-dihydroxybenzohydroxamic acid has been researched along with Glial Cell Tumors in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Figul, M1
Söling, A1
Dong, HJ1
Chou, TC1
Rainov, NG1
Horvath, Z1
Bauer, W1
Hoechtl, T1
Saiko, P1
Fritzer-Szekeres, M1
Tihan, T1
Szekeres, T1

Other Studies

2 other studies available for 3,4-dihydroxybenzohydroxamic acid and Glial Cell Tumors

ArticleYear
Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells.
    Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Benzamidines; Brain Neoplasms; Dacarbazine; Drug Synergism; Enzym

2003
Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.
    Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9

    Topics: Animals; Anti-Infective Agents, Local; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Ant

2004